For many years our patient had been taking an oral contraceptive assoc
iating levonorgestrel and ethinyloestradiol. The appearance of a tempo
ro-malar hirsutism justified the prescription of a new contraceptive a
ssociating ethinyloestradiol and cyproterone acetate. A month later a
bullous skin eruption of porphyria cutanea tarda (PCT) appeared. A tes
t using reintroduction has allowed us to confirm the responsibility of
the cyproterone acetate by making identical clinical lesions reappear
. This report is the first publication in which cyproterone acetate is
proven to induce a PCT eruption.